Selection of a Control Group in BMP Clinical Studies
Gerard E. Riedel(Andover Eye Associates), A. Valentin-Opran(Inserm)
Cited by 1
Related Papers
RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2 FOR TREATMENT OF OPEN TIBIAL FRACTURES
|Journal of Bone and Joint Surgery|2002|1.3k
Recombinant Human BMP-2 and Allograft Compared with Autogenous Bone Graft for Reconstruction of Diaphyseal Tibial Fractures with Cortical Defects
|Journal of Bone and Joint Surgery|2006|447
Clinical Evaluation of Recombinant Human Bone Morphogenetic Protein-2
|Clinical Orthopaedics and Related Research|2002|290
Histomorphometric analysis of sclerotic bone metastases from prostatic carcinoma with special reference to osteomalacia
|Cancer|1983|210
Quantitative histology of myeloma‐induced bone changes
|British Journal of Haematology|1982|179